NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 378 filers reported holding NOVAVAX INC in Q1 2022. The put-call ratio across all filers is 1.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $198,267 | -1.5% | 28,610 | +46.2% | 0.01% | -33.3% |
| Q4 2022 | $201,200 | -91.3% | 19,572 | -84.6% | 0.01% | -87.8% |
| Q3 2022 | $2,316,000 | +146.9% | 127,249 | +603.2% | 0.07% | +174.1% |
| Q2 2022 | $938,000 | -23.3% | 18,096 | +10.6% | 0.03% | +8.0% |
| Q1 2022 | $1,223,000 | -39.8% | 16,367 | +24.7% | 0.02% | -37.5% |
| Q4 2021 | $2,032,000 | -38.8% | 13,126 | -19.5% | 0.04% | -35.5% |
| Q3 2021 | $3,318,000 | -23.8% | 16,304 | -21.8% | 0.06% | -12.7% |
| Q2 2021 | $4,354,000 | +69.9% | 20,839 | +41.0% | 0.07% | +54.3% |
| Q1 2021 | $2,562,000 | +4.2% | 14,784 | -28.5% | 0.05% | -14.8% |
| Q4 2020 | $2,459,000 | -29.0% | 20,667 | -35.6% | 0.05% | -50.9% |
| Q3 2020 | $3,462,000 | +111.6% | 32,070 | +63.9% | 0.11% | +89.7% |
| Q2 2020 | $1,636,000 | – | 19,567 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
| Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
| RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
| Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
| Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
| Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
| Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
| Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
| TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |